ArticleBMC medicine2022

Homologous recombination deficiency (HRD) score in aggressive prostatic adenocarcinoma with or without intraductal carcinoma of the prostate (IDC-P).

Sha Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.